FP7_MC_ITN-VADER

Henderson, Ian (Co-Investigator)
Cunningham, Adam (Co-Investigator)
Gough, Rich (Principal Investigator)

Short title	FP7_MC_ITN-VADER
Status	Finished
Effective start/end date	1/10/12 → 30/09/16

Funding

European Commission - Management Costs
European Commission

1 Article

Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses
Jossi, S., Arcuri, M., Alshayea, A., Persaud, R., Marcial Juarez, E., Palmieri, E., Di Benedetto, R., Perez-Toledo, M., Pillaye, J., Channell, W., Schager, A., Lamerton, R., Jones, C., Goodall, M., Haneda, T., Bäumler, A. J., Jackson-Jones, L. H., Toellner, K., MacLennan, C. & Henderson, I. & 2 others, Micoli, F. & Cunningham, A., 23 Mar 2023, In: Frontiers in immunology. 14, 13 p., 1139329.
Research output: Contribution to journal › Article › peer-review

Open Access
File
135 Downloads (Pure)